• No results found

Certain statements in this presentation constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of

N/A
N/A
Protected

Academic year: 2021

Share "Certain statements in this presentation constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of"

Copied!
18
0
0

Loading.... (view fulltext now)

Full text

(1)

1 1

November 2015

(2)
(3)
(4)
(5)

5

Unique Business Model: “New-to-the-Aftermarket”

Broad Distribution

Global Design, Development and Sourcing Capabilities

Broad Product Portfolio Focuses on ‘Niche’ Offerings

• Virtually no Manufacturing Assets

(6)

6

Industry Dynamics

Industry Dynamics

(7)
(8)
(9)
(10)
(11)
(12)
(13)

13

Sales (in millions) – 5 year CAGR 16%

EPS – 5 year CAGR 27%

(14)

14

Summary Income Statement

Summary Income Statement

Nine Months

Fiscal Year

2014

2015

2013

2014

Net Sales

$

577,495

$

598,123

$ 751,476

664,466

$

Gross Profit

220,484

230,257

260,968

287,201

Margin

38.2%

38.5%

39.3%

38.2%

SG&A

108,361

118,470

133,029

146,467

Op. Income

112,123

111,787

127,939

140,734

Margin

19.4%

18.7%

19.3%

18.7%

Int. and Other

160

152

189

204

Income Taxes

40,632

41,093

45,830

50,543

(15)

15

Summary Balance Sheet

Summary Balance Sheet

December September 2014 2015 Cash 47,656$ $ 79,321 AR 206,035 199,257 Inventory 173,523 195,250 Other current assets 28,250 29,958 P,P & E, net 82,270 86,308 Goodwill and other assets 42,634 49,211 Total Assets $ 580,368 $ 639,305

Debt $ - $

(16)

16 ► Historical cap ex 2‐2.5% of sales excluding one‐time projects$150 million share repurchase program through Dec 2016 • $103.7 million remains at September 2015

Summary Cash Flows

Summary Cash Flows

Nine Months Fiscal Year

2014 2015 2013 2014

Net Income $ 71,331 $ 70,542 $ 81,920 $ 89,987

Dep'n and Amort'n 9,001 11,739 10,159 12,658 Change in AR (8,662) 6,693 (40,791) (25,566) Change in Inventory (12,051) (21,727) (18,537) (13,136) Change in AP (9,168) 377 17,627 (1,558) Other W/C Items (3,045) (10,141) 11,181 (2,745) Operating C/F 47,406 57,483 61,559 59,640 Capital Spending (22,992) (16,534) (24,666) (29,862) Acquisition - (2,000) (1,897) -Share repurchases (41,341) (7,334) (3,489) (43,521) Other Changes 544 50 1,378 806

Net Change in Cash $ (16,383) $ 31,665 $ 32,885 $ (12,937)

(17)
(18)

References

Related documents

Critics o f consociationalism in the South African situation have tended to focus on the follow in g problems: ( 1 ) the relation between »unifying« elite behaviour

This presentation contains statements which constitute forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, including but not

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding our

Effect of the lowest and highest viral cDNA concentrations on shRNA pseudotyped lentiviral particle absolute quantification: comparisons of shRNA lentiviral particle

Certain statements included in this news release constitute “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995

This presentation contains or may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements

This presentation may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that reflect current views of Investar

The total annual precipitation is expected to increase by about 6%–8% for the RCP4.5 scenario and about 10%–18% for the RCP8.5 scenario over the 21st century, despite the higher (up